Department of General Surgery, Xinqiao Hospital, Army Medical University, Chongqing 400037, China.
Department of Neurology, The 942 Hospital of PLA, Yinchuan, Ningxia Hui Autonomous Region, 750001, China.
Curr Mol Pharmacol. 2024;17:e18761429274883. doi: 10.2174/0118761429274883231129103220.
Guanine nucleotide exchange factor H1 (GEF-H1) is a unique protein modulated by the GDP/GTP exchange. As a regulator of the Rho-GTPase family, GEF-H1 can be activated through a microtubule-depended mechanism and phosphorylation regulation, enabling it to perform various pivotal biological functions across multiple cellular activities. These include the regulation of Rho-GTPase, cytoskeleton formation, cellular barrier, cell cycle, mitosis, cell differentiation, and vesicle trafficking. Recent studies have revealed its crucial effect on the tumor microenvironment (TME) components, promoting tumor initiation and progress. Consequently, an in-depth exploration of GEF-H1's biological roles and association with tumors holds promise for its potential as a valuable molecular target in tumor treatment.
鸟嘌呤核苷酸交换因子 H1(GEF-H1)是一种受 GDP/GTP 交换调节的独特蛋白。作为 Rho-GTPase 家族的调节剂,GEF-H1 可以通过微管依赖性机制和磷酸化调节而被激活,使其能够在多种细胞活动中发挥各种关键的生物学功能。这些功能包括调节 Rho-GTPase、细胞骨架形成、细胞屏障、细胞周期、有丝分裂、细胞分化和囊泡运输。最近的研究揭示了它对肿瘤微环境(TME)成分的关键影响,促进了肿瘤的发生和进展。因此,深入探讨 GEF-H1 的生物学作用及其与肿瘤的关联有望使其成为肿瘤治疗有价值的分子靶点。